A reticulated python found in Indonesia broke the Guinness World Record for the longest, scientifically measured wild snake ...
Canopy Network has announced it is launching Canopy Templates, a new blockchain building tool designed to aid in AI-assisted development.
PyPy, an alternative runtime for Python, uses a specially created JIT compiler to yield potentially massive speedups over CPython, the conventional Python runtime. But PyPy’s exemplary performance has ...
A manager assigns a team member to an unglamorous task. A senior colleague hands off a notoriously difficult client to a junior colleague. Someone must assume extra ...
The Chicago area isn't dealing with the remnants of a massive snowfall, but rather a much different type of winter weather: extreme cold. While accumulating snow is possible in the coming days, Friday ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...
States are banning cellphones in schools, but do these policies actually work to improve student behavior and achievement? A pair of research projects led by noted academic scholars provide some ...
Hosted on MSN
Where Will Recursion Pharmaceuticals Be in 5 Years?
Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results